We demonstrated the crosstalk between the EZH2/H3K27me3/DNMT1 complex and AP-2α methylation in gliomas (Fig. S9), suggesting that AP-2α methylation may be a critical epigenetic mechanism in glioblastoma. The gene discussed is EZH2; the disease is central nervous system cancer.